Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Prospective, Double-blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis.

NCT00258609 is registered in ClinicalTrials.gov with Department of Medical Services Ministry of Public Health of Thailand as lead sponsor.

NCT NCT00258609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00258609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Prospective, Double-blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis.
Lead sponsor
Department of Medical Services Ministry of Public Health of Thailand
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
June 30, 2004
Enrollment
128
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

migraine without aura prophylaxis